The levels of TTR, measured with the same nephelemetric method, were found to be significantly reduced in AD, with significantly-lower levels in patients with severe AD compared with mild forms; moreover a 15 ng/mL cut off value was established that was highly prognostic of the severity of the disease [70]. The gene discussed is TTR; the disease is Alzheimer disease.